U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07657650) titled 'FAPl Imaging Assessment of Revascularization Outcome in Ischemic Heart Failure' on June 15.
Brief Summary: Ischemic heart failure (IHF) is the final stage of coronary heart disease. Coronary revascularization is an important treatment method for IHF, but it has high perioperative risks and not all patients can benefit from it. Evaluation of viable myocardium is one of the important decision-making methods for IHF, but recent research results have raised doubts about its value. The clinical community urgently needs more precise and comprehensive non-invasive decision-making methods. Fibroblast activation protein inhibitor (FAPI) imag...